semaglutide elisa kit detection Human Anti-Semaglutide Neutralizing antibody Semaglutide QuickTest ELISA Kit -

Discover how once-monthly maridebart cafraglutide for the treatment of obesity works, its clinical trial evidence, potential eligibility criteria, side effects, and the pathway to NHS access if approved by UK regulators.

Discover a brand new approach to obesity treatment

Get insights on navigating GLP-1 antagonist shortages and compounds as we navigate demand and supply challenges.

Find out what my experience was like.

The global incretin-based drugs market was valued at USD 39.4 billion in 2025 and is projected to grow from USD 41.6 billion in 2026 to USD 72.6 billion by 2035, expanding at a CAGR of 6.4% between 2026 and 2035, driven by the rising prevalence of type 2 diabetes mellitus.

We share realistic protein targets, the easiest formats to tolerate, and dietitian-tested powders and shakes that work in real life.